Quarterly report pursuant to Section 13 or 15(d)

GOODWILL & INTANGIBLE ASSETS

v3.23.2
GOODWILL & INTANGIBLE ASSETS
6 Months Ended
Jun. 30, 2023
GOODWILL & INTANGIBLE ASSETS  
GOODWILL & INTANGIBLE ASSETS

11. GOODWILL & INTANGIBLE ASSETS

The carrying amount of goodwill at June 30, 2023 and December 31, 2022 was $112.7 million and $113.0 million respectively, and has been recorded in connection with the Company’s acquisitions. The goodwill activity is as follows (in thousands):

June 30, 

December 31, 

2023

2022

Balance, beginning of year

$

112,955

$

639,301

Foreign currency translation adjustment

(214)

(26,940)

Measurement period adjustments

(606)

Goodwill impairment

(498,800)

Balance, end of period

$

112,741

$

112,955

The measurement period adjustments of $0.6 million during 2022 represent the final measurement period adjustments related to the acquisition of May Dental Lab, Inc. in October 2021 and the acquisition of the ExOne Company in November 2021.

Due to sustained declines in the Company’s stock price and the stock prices of comparable companies, the Company performed interim quantitative assessments as of June 30, 2022 and December 31, 2022, utilizing a combination of the income and market approaches. The results of the quantitative analysis performed indicated that the carrying value of the reporting unit exceeded the fair value. As such, $498.8 million of goodwill impairment charges were recorded during the year ended December 31, 2022.

The Company estimated the fair value using a weighted average of the income and market approaches. Specifically, the discounted cash flow method was used under the income approach and the guideline public company and guideline merged and acquired company methods were used under the market approach. The significant assumptions used under the income approach include management’s forecasts of future revenues and EBITDA margins used to calculate projected future cash flows, discount rates,

and the terminal growth rate. The terminal value is based on an exit revenue multiple which requires significant assumptions regarding the selections of appropriate multiples that consider relevant market trading data. The Company bases its estimates and assumptions on its knowledge of the additive manufacturing industry, recent performance, expectations of future performance and other assumptions the Company believes to be reasonable. The significant assumptions used under the market approach include the control premium and selection of comparable companies and comparable transactions. Comparable companies and transactions are chosen based on factors including industry classification, geographic region, product offerings, earnings growth, and profitability.

During the three and six months ended June 30, 2023, the Company did not record a goodwill impairment charge. During the three and six months ended June 30, 2022, the Company recorded a goodwill impairment charge of $229.5 million in the condensed consolidated statements of operations.

Intangible assets consisted of the following (in thousands):

June 30, 2023

 

December 31, 2022

Weighted Average

Gross

Net

    

Gross

Net

Remaining Useful

Carrying

Accumulated

Carrying

Carrying

Accumulated

Carrying

Lives (in years)

Amount

Amortization

Amount

 

Amount

Amortization

Amount

Acquired technology

8.2

$

197,022

$

51,990

$

145,032

 

$

196,367

$

36,919

$

159,448

Trade name

10.0

12,464

3,205

9,259

12,459

2,374

10,085

Customer relationships

9.4

68,123

22,805

45,318

67,915

17,663

50,252

Capitalized software

518

518

518

473

45

Total intangible assets

$

278,127

$

78,518

$

199,609

$

277,259

$

57,429

$

219,830

During the three and six months ended June 30, 2023 and 2022, the Company recognized the following amortization expense (in thousands):

Statement of

Three Months Ended June 30, 

    

Six Months Ended June 30, 

Category

Operations Line Item

2023

2022

2023

2022

Acquired technology

Cost of Sales

$

6,928

$

5,950

$

13,855

$

11,940

Acquired technology

Research and Development

556

405

1,109

848

Trade name

General and Administrative

418

421

833

843

Customer relationships

Sales and Marketing

2,537

2,866

5,057

5,768

Capitalized software

Research and Development

18

27

45

54

$

10,457

$

9,669

$

20,899

$

19,453

The Company expects to recognize the following amortization expense (in thousands):

Amortization Expense

2023 (remaining 6 months)

$

20,879

2024

41,878

2025

39,372

2026

29,322

2027

21,076

2028 and after

47,082

Total intangible amortization

$

199,609